No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis

No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis

Background: Platelet-activating factor (PAF) seems to be implicated in systemic lupus erythematosus (SLE) patients with associated renal diseases.Aims: In this study, we ensured the role of PAF in SLE patients without renal complications.

Bibliographic Details
Main Authors: Yves Denizot, Eric Liozon, Laurence Guglielmi, Kim Ly, Pascale Soria, Véronique Loustaud, Elisabeth Vidal, Marie Odile Jauberteau
Format: Article
Language:English
Published: Hindawi Limited 2003-01-01
Series:Mediators of Inflammation
Subjects:
Acetylhydrolase activity
Platelet-activating factor
Soluble phospholipase A2
Systemic lupus erythematosus.
Online Access:http://dx.doi.org/10.1080/0962935031000097718
id doaj-630bb36c32034486ad227f55060d365c
record_format Article
spelling doaj-630bb36c32034486ad227f55060d365c2020-11-25T00:53:38ZengHindawi LimitedMediators of Inflammation0962-93511466-18612003-01-0112210110510.1080/0962935031000097718No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritisYves Denizot0Eric Liozon1Laurence Guglielmi2Kim Ly3Pascale Soria4Véronique Loustaud5Elisabeth Vidal6Marie Odile Jauberteau7UMR CNRS 6101, Laboratoire d'Immunologie, Faculté de Médecine, 2 rue Dr Marcland, Limoges 87025, FranceService de Médecine Interne, CHU Dupuytren, Limoges, FranceUMR CNRS 6101, Laboratoire d'Immunologie, Faculté de Médecine, 2 rue Dr Marcland, Limoges 87025, FranceService de Médecine Interne, CHU Dupuytren, Limoges, FranceService de Médecine Interne, CHU Dupuytren, Limoges, FranceService de Médecine Interne, CHU Dupuytren, Limoges, FranceService de Médecine Interne, CHU Dupuytren, Limoges, FranceUMR CNRS 6101, Laboratoire d'Immunologie, Faculté de Médecine, 2 rue Dr Marcland, Limoges 87025, FranceBackground: Platelet-activating factor (PAF) seems to be implicated in systemic lupus erythematosus (SLE) patients with associated renal diseases.Aims: In this study, we ensured the role of PAF in SLE patients without renal complications.http://dx.doi.org/10.1080/0962935031000097718Acetylhydrolase activityPlatelet-activating factorSoluble phospholipase A2Systemic lupus erythematosus.
collection DOAJ
language English
format Article
sources DOAJ
author Yves Denizot
Eric Liozon
Laurence Guglielmi
Kim Ly
Pascale Soria
Véronique Loustaud
Elisabeth Vidal
Marie Odile Jauberteau
spellingShingle Yves Denizot
Eric Liozon
Laurence Guglielmi
Kim Ly
Pascale Soria
Véronique Loustaud
Elisabeth Vidal
Marie Odile Jauberteau
No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis
Mediators of Inflammation
Acetylhydrolase activity
Platelet-activating factor
Soluble phospholipase A2
Systemic lupus erythematosus.
author_facet Yves Denizot
Eric Liozon
Laurence Guglielmi
Kim Ly
Pascale Soria
Véronique Loustaud
Elisabeth Vidal
Marie Odile Jauberteau
author_sort Yves Denizot
title No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis
title_short No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis
title_full No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis
title_fullStr No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis
title_full_unstemmed No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis
title_sort no evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis
publisher Hindawi Limited
series Mediators of Inflammation
issn 0962-9351
1466-1861
publishDate 2003-01-01
description Background: Platelet-activating factor (PAF) seems to be implicated in systemic lupus erythematosus (SLE) patients with associated renal diseases.Aims: In this study, we ensured the role of PAF in SLE patients without renal complications.
topic Acetylhydrolase activity
Platelet-activating factor
Soluble phospholipase A2
Systemic lupus erythematosus.
url http://dx.doi.org/10.1080/0962935031000097718
work_keys_str_mv AT yvesdenizot noevidenceforaputativeinvolvementofplateletactivatingfactorinsystemiclupuserythematosuswithoutactivenephritis
AT ericliozon noevidenceforaputativeinvolvementofplateletactivatingfactorinsystemiclupuserythematosuswithoutactivenephritis
AT laurenceguglielmi noevidenceforaputativeinvolvementofplateletactivatingfactorinsystemiclupuserythematosuswithoutactivenephritis
AT kimly noevidenceforaputativeinvolvementofplateletactivatingfactorinsystemiclupuserythematosuswithoutactivenephritis
AT pascalesoria noevidenceforaputativeinvolvementofplateletactivatingfactorinsystemiclupuserythematosuswithoutactivenephritis
AT veroniqueloustaud noevidenceforaputativeinvolvementofplateletactivatingfactorinsystemiclupuserythematosuswithoutactivenephritis
AT elisabethvidal noevidenceforaputativeinvolvementofplateletactivatingfactorinsystemiclupuserythematosuswithoutactivenephritis
AT marieodilejauberteau noevidenceforaputativeinvolvementofplateletactivatingfactorinsystemiclupuserythematosuswithoutactivenephritis
_version_ 1725237303846109184

Similar Items